Abstract: A framework for an improved destruction of interrelated data objects is described herein. In one embodiment, destruction and/or archiving of data objects are decoupled from the destruction and/or archiving of a master data object by using a backup table. Before being destructed, attributes relevant to destruction of dependent data objects are copied from the master data object to the backup table. Subsequent destruction operations performed on data objects dependent on the master data object may attempt to retrieve the attributes relevant to destruction from the master data object itself, or from the backup table. In this way, data object destruction orderings are avoided, enabling dependent data objects to be destructed at any time.

Abstract: A framework for an improved destruction of interrelated data objects is described herein. In one embodiment, destruction and/or archiving of data objects are decoupled from the destruction and/or archiving of a master data object by using a backup table. Before being destructed, attributes relevant to destruction of dependent data objects are copied from the master data object to the backup table. Subsequent destruction operations performed on data objects dependent on the master data object may attempt to retrieve the attributes relevant to destruction from the master data object itself, or from the backup table. In this way, data object destruction orderings are avoided, enabling dependent data objects to be destructed at any time.

Abstract: The pharmaceutical preparation for oral contraception has 28 daily dosage units, of which at least 21 daily dosage units each contain from 1.5 mg to 2 mg of dienogest and from 0.015 mg to 0.02 mg of ethinyl estradiol together in a pharmaceutically acceptable carrier. Seven or fewer daily dosage units contain no effective ingredient. Each daily dosage unit can be a film tablet for oral administration, which has a tablet core and film coating on the tablet core. At least 30% of the dienogest is released from the tablet core preferably in a delayed manner after more than 30 minutes, while at least 70% of the dienogest and ethinyl estradiol are released from the film coating preferably in 30 minutes, as determined by a standard dissolution test.